United Therapeutics Corp
Change company Symbol lookup
Select an option...
UTHR United Therapeutics Corp
AZRE Azure Power Global Ltd
KGAUF Kongsberg Automotive ASA
FGMCU FG Merger Corp
RSG Republic Services Inc
EBON Ebang International Holdings Inc
MMV MultiMetaVerse Holdings Limited
TMUS T-Mobile US Inc
ADBE Adobe Inc
YJ Yunji Inc
Go

Health Care : Biotechnology | Mid Cap Value
Company profile

United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Tyvaso (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso and Tyvaso DPI are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKinds Afrezza (insulin human) Inhalation Powder product.

Closing Price
$217.22
Day's Change
3.74 (1.75%)
Bid
--
Ask
--
B/A Size
--
Day's High
217.68
Day's Low
212.99
Volume
(Average)
Volume:
392,075

10-day average volume:
430,000
392,075
  • Prev Close
    213.48
  • Today's Open
    214.52
  • Day's Range
    212.99-217.68
  • Avg Vol (10-day)
    430.0K
  • Last (time)
    4:00p ET 06/02/23
  • Last (size)
    2
  • 52-Wk Range
    201.65 - 283.09
    LowHigh
  • (09/22/22 - 12/09/22)
    7.72%
  • 27.4%
  • Market Cap
    10.2B
  • Shares Outstanding
    46.9M
  • 14.86
  • 14.62x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 97.28
  • (% of float 05/15/23)
    2.91

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.